Exact Sciences broke ground on its new corporate headquarters building at University Research Park, calling it Innovation One, the company announced recently. According to a release, the 138,000 square-foot building,…
The Madison community is important to the success of Exact Sciences, CEO Kevin Conroy said at the annual shareholder meeting held today at the Edgewater Hotel. “If you have a…
Exact Sciences, along with researchers at the Mayo Clinic, announced today that they have developed a blood test that correctly identified 95 percent of the cases of a common form…
Exact Sciences named Mark Stenhouse as president of Cologuard, its noninvasive stool DNA-based test for early detection of colon cancer, the company announced recently. “More than 85 million people are…
Exact Sciences named Paul J. Limburg, M.D., M.P.H., as its co-chief medical officer, the company announced today. “Dr. Limburg’s valuable mix of cancer prevention experience in both the clinical and…
Exact Sciences’ Cologuard has been used in more than one million screenings for colorectal cancer, the company announced today. “Approximately half of Cologuard users haven’t been screened before, and we’re…
Exact Sciences and the Urban League of Greater Madison (ULGM) have partnered to highlight how businesses and non-profit organizations can work together to strengthen the community, the organization announced recently. According…
Due to high Cologuard demand and a growing workforce, Exact Sciences announced recently it is building an additional facility at 650 Forward Dr. “Doctors and patients are increasingly choosing the convenience of…
Exact Sciences recently announced its second quarter numbers, which included revenue of $57.6 million and 135,000 completed Cologuard tests, an increase of 172 percent and 149 percent, respectively. “As patient and…
To help raise awareness of colon cancer and the importance of regular screening, professional golfer Jerry Kelly will wear a Cologuard-branded hat for the next two years, Exact Sciences announced…
